Search For "cova"
India's vaccination drive outpaces most countries as it breaches 100 cr in
Updated : 4 years, 4 months ago IST
New Delhi [India], October 21 (ANI): With an uptick in the world's largest vaccination drive against COVID-19, India on Thursday crossed inoculation of 100 crore vaccine doses, according to the Ministry of Health and Family Welfare.
Read More
As India reaches 100 crore vaccinations, a look at its basket of COVID-19
Updated : 4 years, 4 months ago IST
New Delhi [India], October 21 (ANI): As India achieved the milestone of vaccinating over 100 crore citizens on Thursday, we take look at the basket of vaccines developed, manufactured or in use in the country.
Read More
Administration of ZyCoV-D vaccine requires special training; awaiting NTAG
Updated : 4 years, 4 months ago IST
New Delhi [India], October 21 (ANI): Zydus Cadila's vaccine - ZyCoV-D is the first indigenously manufactured needle-free Covid-19 vaccine which is approved for children aged above 12 for emergency use in the country. Earlier, the Subject Experts Committee (SEC) has also recommended the Hy
Read More
Expecting 'one' additional information on Covaxin, decision on emergency u
Updated : 4 years, 4 months ago IST
Geneva [Switzerland], October 18 (ANI): World Health Organisation (WHO), which is reviewing the data provided by Bharat Biotech for Emergency Use Listing of COVID-19 vaccine Covaxin, said on Monday that it is "expecting one additional piece of information from the company today".
Read More
WHO's advisory group to meet on Oct 26 to consider Covaxin's emergency usa
Updated : 4 years, 4 months ago IST
Geneva [Switzerland], October 17 (ANI): Dr Soumya Swaminathan, World Health Organisation (WHO) chief scientist on Sunday informed that WHO's technical advisory group will meet on October 26 to consider emergency use listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covax
Read More
India to procure over 30 crore COVID-19 vaccine doses per month by January
Updated : 4 years, 5 months ago IST
New Delhi [India], October 16 (ANI): India will have a vaccine capacity of 28 crore doses this month, which includes 22 crore Serum Institute of India's Covishield and 6 crore doses of Bharat Biotech Biotech's Covaxin and production of 60 lakh Zydus Cadila's ZyCoV-D doses are also ready,
Read More
US donates 9.6mn additional Covid vaccine doses to Pakistan
Updated : 4 years, 5 months ago IST
Washington [US], October 16 (ANI): As many as 9.6 million doses of Pfizer COVID-19 vaccine are being shipped by the United States to Pakistan through the global vaccine-sharing COVAX initiative, a media report said on Friday.
Read More
I'm sure approval of Covaxin from WHO will come at soonest possible, says
Updated : 4 years, 5 months ago IST
Bhubaneswar (Odisha) [India], October 15 (ANI): Foreign Secretary Harsh Vardhan Shringla on Thursday expressed hope that the World Health Organisation (WHO) will soon give approval to Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin.
Read More
Covaxin's approval for children aged 2-18 yrs under experts' opinion, eval
Updated : 4 years, 5 months ago IST
New Delhi [India], October 14 (ANI): The final approval for Bharat Biotech's Covaxin for children aged 2-18 years is under experts opinion and evaluation, stated Government sources on Thursday.
Read More
India exports 10 crore Covid-19 jabs each to Bangladesh, Nepal, Myanmar, I
Updated : 4 years, 5 months ago IST
New Delhi [India], October 14 (ANI): After the resumption of export of COVID-19 vaccines in October, India has exported 10 crore vaccines each to Nepal, Myanmar, Iran and Bangladesh under Vaccine Maitri, said the government sources.
Read More
60 lakh vaccine doses of ZyCoV-D are ready after production in October: So
Updated : 4 years, 5 months ago IST
New Delhi [India], October 13 (ANI): As many as 60 lakh doses of Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D are ready after production, said government sources.
Read More
Awaiting regulatory approval for rolling out Covaxin for children aged 2-1
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): The Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's COVID-19 vaccine, Covaxin, for the beneficiaries aged between 2-18 years, the official sources said on Tuesday
Read More